Get the Stockscreener App
1.55
4.91%
-0.08
Galmed Pharmaceuticals Ltd stock is traded at $1.55, with a volume of 238.21K.
It is down -4.91% in the last 24 hours and down -12.92% over the past month.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
See More
Previous Close:
$1.63
Open:
$1.61
24h Volume:
238.21K
Relative Volume:
0.30
Market Cap:
$8.46M
Revenue:
-
Net Income/Loss:
$-6.91M
P/E Ratio:
-0.4755
EPS:
-3.26
Net Cash Flow:
$-6.14M
1W Performance:
-22.11%
1M Performance:
-12.92%
6M Performance:
-44.24%
1Y Performance:
-57.68%
1-Day Range:
$1.48
$1.61
1-Week Range:
$1.48
$2.03
52-Week Range:
$1.15
$23.80
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Name
Galmed Pharmaceuticals Ltd
Sector
Industry
Phone
-
Address
-
Compare GLMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.55 | 3.68M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-22-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Feb-04-20 | Initiated | Craig Hallum | Buy |
| Jan-30-20 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-02-19 | Initiated | Canaccord Genuity | Buy |
| Dec-12-18 | Initiated | B. Riley FBR | Buy |
| Aug-02-18 | Reiterated | Maxim Group | Buy |
| Jul-13-18 | Initiated | Stifel | Buy |
| Jul-12-18 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-12-18 | Reiterated | H.C. Wainwright | Buy |
| Mar-15-18 | Upgrade | Maxim Group | Hold → Buy |
| Feb-14-18 | Downgrade | Maxim Group | Buy → Hold |
| Feb-12-18 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-17 | Initiated | ROTH Capital | Buy |
| Aug-08-17 | Reiterated | H.C. Wainwright | Buy |
| Jul-31-17 | Reiterated | Maxim Group | Buy |
| Aug-01-16 | Reiterated | Maxim Group | Buy |
| Jul-06-16 | Resumed | ROTH Capital | Buy |
| Mar-28-16 | Resumed | H.C. Wainwright | Buy |
| Jun-23-15 | Initiated | H.C. Wainwright | Buy |
| May-06-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Galmed Pharmaceuticals Ltd Stock (GLMD) Latest News
Volatility clustering patterns for Galmed Pharmaceuticals Ltd.Machine Learning Intraday Signal Forecast - Newser
Why Galmed Pharmaceuticals Ltd. stock attracts strong analyst attentionEquity Portfolio Outlook and Performance Summary - Newser
What moving averages say about Galmed Pharmaceuticals Ltd.Free Multi-Bagger Potential Stock Forecast Tools - Newser
What is the dividend policy of Galmed Pharmaceuticals Ltd. stockMarket Forecast Signals For Fast Growth - jammulinksnews.com
How does Galmed Pharmaceuticals Ltd. compare to its industry peersStock Market Opportunities For Beginners - jammulinksnews.com
Technical signs of recovery in Galmed Pharmaceuticals Ltd.Market Timing Strategy with Technical Filters - Newser
Identifying reversal signals in Galmed Pharmaceuticals Ltd.Swing Trade Planning with Consistent Setup - Newser
Real time pattern detection on Galmed Pharmaceuticals Ltd. stockIntraday Strategy with Real Time Monitoring - Newser
When is Galmed Pharmaceuticals Ltd. stock expected to show significant growthReal Time Guidance From AI Tools - jammulinksnews.com
What are analysts’ price targets for Galmed Pharmaceuticals Ltd. in the next 12 monthsWealth Building Signals From AI Tools - jammulinksnews.com
Quantitative breakdown of Galmed Pharmaceuticals Ltd. recent moveChart Confirmation Setup with ROI Signals - Newser
Galmed Pharmaceuticals Ltd. Recovers — But Is It SustainableSwing Trading Plan With Smart Signals in Review - metal.it
Is Galmed Pharmaceuticals Ltd. Stock a Good Fit for Conservative InvestorsSmart Swing Picks with Confirmed Signals - Newser
How Galmed Pharmaceuticals Ltd. stock performs during market volatilityCommunity Shared Smart Money Signals Show Movement - metal.it
Published on: 2025-07-29 06:42:13 - Newser
Is Galmed Pharmaceuticals Ltd. Stock Overbought or Oversold RSI Indicator AnalysisFree Access to Real-Time Trade Insights - Newser
What are the latest earnings results for Galmed Pharmaceuticals Ltd.Top Growth Signals From AI Tools - jammulinksnews.com
What are the technical indicators suggesting about Galmed Pharmaceuticals Ltd.Find market-beating stocks for your portfolio - jammulinksnews.com
Should I hold or sell Galmed Pharmaceuticals Ltd. stock in 2025Free Investment Case Studies - jammulinksnews.com
Why is Galmed Pharmaceuticals Ltd. stock attracting strong analyst attentionHigh-octane financial growth - jammulinksnews.com
How does Galmed Pharmaceuticals Ltd. generate profit in a changing economyAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
What is the risk reward ratio of investing in Galmed Pharmaceuticals Ltd. stockMaximize your returns with portfolio optimization - jammulinksnews.com
What is Galmed Pharmaceuticals Ltd. company’s growth strategyInvest confidently with real-time data analysis - jammulinksnews.com
What makes Galmed Pharmaceuticals Ltd. stock price move sharplyFree Professional Portfolio Management - Newser
Galmed Pharmaceuticals (NASDAQ:GLMD) Upgraded to Hold at Wall Street Zen - Defense World
What drives Galmed Pharmaceuticals Ltd. stock priceExceptional profit potential - PrintWeekIndia
Galmed Pharmaceuticals to Hold Special Meeting on Share Capital Increase - TipRanks
What analysts say about Galmed Pharmaceuticals Ltd. stockFree Stock Market Beginners Guide - Autocar Professional
Galmed Pharmaceuticals Ltd. Stock Analysis and ForecastMarket-crushing stock picks - Autocar Professional
Is Galmed Pharmaceuticals Ltd. a good long term investmentTurbocharged investment results - jammulinksnews.com
Galmed Pharmaceuticals Ltd Stock (GLMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):